[1] Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association [J]. Stroke, 2014, 45(12): 3754-3832. [2] 唐强,朱路文. 脑卒中康复新策略——针康法[J]. 中国康复医学杂志, 2015, 30(10): 1071-1073. [3] Greenberg DA, Jin K. Vascular endothelial growth factors (VEGFs) and stroke [J]. Cell Mol Life Sci, 2013, 70(10): 1753-1761. [4] Shibuya M. VEGF-VEGFR system as a target for suppressing inflammation and other diseases [J]. Endocr Metab Immune Disord Drug Targets, 2015, 15(2): 135-144. [5] Tang Y, Wang J, Lin X, et al. Neural stem cell protects aged rat brain from ischemia-reperfusion injury through neurogenesis and angiogenesis [J]. J Cereb Blood Flow Metab, 2014, 34(7): 1138-1147. [6] Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats [J]. Stroke, 1989, 20(1): 84-91. [7] 唐强,姜云飞,朱路文,等. 针康法对局灶性脑缺血大鼠神经功能缺损及缺血区碱性成纤维细胞生长因子, 血管抑制素蛋白表达的影响[J]. 中国康复理论与实践, 2015, 21(10): 1151-1155. [8] Chen J, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats [J]. Stroke, 2001, 32(4): 1005-1111. [9] 唐强,叶涛,朱路文,等. 针康法对脑缺血大鼠神经功能和细胞外信号调节激酶1/2信号通路的影响[J]. 中国康复理论与实践, 2017, 23(1): 27-31. [10] 唐强,刘宏光,王艳,等. 针康法对局灶性脑缺血大鼠前肢运动功能及缺血区突触素和生长相关蛋白-43表达的影响[J]. 中国康复理论与实践, 2011, 17(10): 973-976. [11] 唐强,叶涛,朱路文,等. 针康法对局灶性脑梗死大鼠神经功能缺损及梗死灶周边区RhoA, ROCK-Ⅱ蛋白表达的影响[J]. 针灸临床杂志, 2016, 32(8): 73-77. [12] 唐强,朱路文,邢艳丽,等. 针康法对脑缺血大鼠运动功能及GAP-43, Nogo-A表达的影响[J]. 针灸临床杂志, 2015, 31(1): 54-57. [13] 朱路文,唐强,李季,等. 针康法对脑缺血大鼠脑组织 VEGF, LN表达的影响[J]. 针灸临床杂志, 2015, 31(10): 71-74. [14] 朱路文,唐强,王艳,等. 针康法对脑缺血后神经血管单元重塑的影响[J]. 针灸临床杂志, 2016, 32(6): 70-73. [15] 赵振峰,王芳,刘宏光,等. 针康法对局灶性脑缺血大鼠学习记忆能力及海马基质细胞衍生因子-1α mRNA的影响[J]. 中国康复理论与实践, 2011, 17(4): 307-309. [16] 周海纯. 针康法对大鼠脑梗死后内源性神经干细胞增殖迁移分化影响的研究[D]. 哈尔滨:黑龙江中医药大学, 2008. [17] Zhang ZG, Zhang L, Jiang Q, et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain [J]. J Clin Invest, 2000, 106(7): 829-838. [18] 杨赫,唐强. 血管内皮生长因子在缺血性脑卒中的研究进展[J]. 医学综述, 2014, 20(21): 3848-3850. [19] Shibuya M. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases [J]. J Biochem, 2013, 153(1): 13-19. [20] Wittko-Schneider IM, Schneider FT, Plate KH. Brain homeostasis: VEGF receptor 1 and 2–two unequal brothers in mind [J]. Cell Mol Life Sci, 2013, 70(10): 1705-1725. [21] Xie L, Mao X, Jin K, et al. Vascular endothelial growth factor-B expression in postischemic rat brain [J]. Vasc Cell, 2013, 5(1): 1. [22] Chappell JC, Mouillesseaux KP, Bautch VL. Flt-1 (vascular endothelial growth factor receptor-1) is essential for the vascular endothelial growth factor-Notch feedback loop during angiogenesis [J]. Arterioscler Thromb Vasc Biol, 2013, 33(8): 1952-1959. [23] 刘娟,栾松,李浩东,等. 补阳还五汤对大鼠局灶性脑缺血损伤及再灌注损伤的治疗作用与保护机制[J]. 中医药导报, 2014, 20(11): 93-95. [24] Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions [J]. Clin Sci (Lond), 2005, 109(3): 227-241. [25] Olsson AK, Dimberg A, Kreuger J, et al. VEGF receptor signalling? In control of vascular function [J]. Nat Rev Mol Cell Biol, 2006, 7(5): 359-371. |